Nursing Elites

1. What is a common sign of developmental dysplasia of the hip (DDH) in infants?

• A. Dislocated patella
• B. Limited abduction of the hip
• C. Swelling of the knee
• D. Hyperextension of the leg

Correct answer: B

Rationale: Limited abduction of the hip is a common sign of developmental dysplasia of the hip in infants. It indicates possible hip dislocation or instability, making it a key clinical manifestation to assess for DDH. Dislocated patella (Choice A) is not typically associated with DDH. Swelling of the knee (Choice C) and hyperextension of the leg (Choice D) are not specific signs linked to DDH in infants, further supporting why they are incorrect choices.

2. What is a long-term complication of cleft lip and palate?

• A. Cognitive impairment
• B. Altered growth and development
• C. Faulty dentition
• D. Physical abilities

Correct answer: C

Rationale: The correct long-term complication of cleft lip and palate is faulty dentition. Individuals with cleft lip and palate may experience dental issues such as missing, extra, or misaligned teeth, which can affect speech and the aesthetic appearance of the mouth. Cognitive impairment, as mentioned in choice A, is not a typical long-term complication associated with cleft lip and palate. While altered growth and development (choice B) can be affected during early stages, it is not a prominent long-term complication. Choice D, physical abilities, is not directly related to the typical long-term complications of cleft lip and palate.

3. What is a common complication of untreated type 1 diabetes in children?

• A. Diabetic ketoacidosis
• B. High blood pressure
• C. Asthma
• D. Frequent infections

Correct answer: A

Rationale: Diabetic ketoacidosis is a serious complication of untreated type 1 diabetes in children. It is characterized by high blood sugar levels, ketones in the urine, and acidosis. Prompt medical attention is required to manage this condition. High blood pressure (Choice B) can be a complication of diabetes but is not as directly linked to untreated type 1 diabetes as diabetic ketoacidosis. Asthma (Choice C) and frequent infections (Choice D) are not typically associated with untreated type 1 diabetes in children.

4. How should a healthcare provider address a child's concerns about a new medical diagnosis?

• A. Provide clear and age-appropriate information
• B. Avoid discussing the diagnosis
• C. Refer to a specialist immediately
• D. Suggest seeking alternative therapies

Correct answer: A

Rationale: Correct answer: Providing clear and age-appropriate information is crucial when addressing a child's concerns about a new medical diagnosis. Children often feel anxious and confused when faced with health issues, so offering them information in a way they can understand helps alleviate their fears and empowers them to cope better. Choice B is incorrect because avoiding discussing the diagnosis can lead to increased anxiety and uncertainty in the child. Choice C is incorrect as referring to a specialist immediately may not be necessary at the initial stage of addressing the child's concerns. Choice D is incorrect as suggesting alternative therapies without providing proper information about the medical diagnosis may not be suitable or effective.

5. What should be monitored in a child receiving chemotherapy?

• A. Blood glucose levels
• B. Blood cell counts
• C. Weight gain
• D. Skin elasticity

Correct answer: B

Rationale: The correct answer is monitoring blood cell counts. During chemotherapy, it is crucial to monitor blood cell counts to detect potential side effects such as neutropenia (low white blood cell count) and anemia (low red blood cell count). These conditions can increase the risk of infections and fatigue. Monitoring blood glucose levels (Choice A) is not typically a primary concern in children receiving chemotherapy unless they have pre-existing conditions like diabetes. Weight gain (Choice C) and skin elasticity (Choice D) are not directly related to monitoring the effects of chemotherapy in children. Therefore, the most important parameter to monitor in a child receiving chemotherapy is blood cell counts.

Similar Questions